Imunon awarded Executive Chairman Michael H. Tardugno 5,824 shares at $1.47 per share on Sep. 11, 2026. The award represented about 6.1% of his resulting 95,699-share Imunon holding, giving investors a specific view of the transaction’s size and reported post-award ownership.
Key Highlights
- Michael H. Tardugno’s Imunon ownership stood at 95,699 shares after the award.
- The transaction occurred on Sep. 11, 2026.
- Transaction code A classifies the transaction as an award or grant.
Imunon, Inc. (NASDAQ: IMNN) awarded Executive Chairman Michael H. Tardugno 5,824 shares at $1.47 per share. The filing reports the award price and the resulting ownership for the executive chairman.
Award Adds 5,824 Imunon Shares
Tardugno received the Imunon shares on Sep. 11, 2026. Tardugno held 95,699 Imunon shares after the transaction. The filing reports an award price of $1.47 per share. The filing reports the award and Tardugno’s resulting ownership.
Award Represented 6.1% of Resulting Holding
The filing states that the transaction represents about 6.1% of Tardugno’s resulting shares holding. The filing identifies the size of the award and its stated proportion of Tardugno’s resulting position. The figures apply to this transaction and the ownership recorded after it.
FAQs
Q: How many shares did Imunon award Michael Tardugno?
A: Imunon awarded Executive Chairman Michael H. Tardugno 5,824 shares. The filing reports the award price as $1.47 per share, and the transaction occurred on September 11, 2026.
Q: What was Michael Tardugno’s Imunon shareholding after the award?
A: Tardugno held 95,699 Imunon shares after the transaction. The filing reports this resulting ownership following the award of 5,824 shares.
Q: What does transaction code A mean for the Imunon share award?
A: Transaction code A identifies an award or grant. In this case, it classified the 5,824 Imunon shares awarded to Tardugno on Sep. 11, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.